Compare RNA & CNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNA | CNR |
|---|---|---|
| Founded | 2012 | 1864 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Coal Mining |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.1B |
| IPO Year | 2020 | N/A |
| Metric | RNA | CNR |
|---|---|---|
| Price | $71.76 | $83.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 5 |
| Target Price | $69.26 | ★ $110.10 |
| AVG Volume (30 Days) | ★ 2.9M | 798.9K |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 0.48% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $20,868,000.00 | ★ $3,724,700,000.00 |
| Revenue This Year | $64.11 | $91.41 |
| Revenue Next Year | $37.25 | $9.46 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 106.27 | 68.14 |
| 52 Week Low | $21.51 | $58.19 |
| 52 Week High | $71.79 | $125.78 |
| Indicator | RNA | CNR |
|---|---|---|
| Relative Strength Index (RSI) | 77.56 | 53.93 |
| Support Level | $71.42 | $76.73 |
| Resistance Level | $71.76 | $80.56 |
| Average True Range (ATR) | 0.41 | 3.37 |
| MACD | -0.73 | 0.63 |
| Stochastic Oscillator | 88.32 | 82.22 |
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
Core Natural Resources Inc is a producer and exporter of coal. The company owns and operates longwall mining operations in the nation and export terminals on the Eastern seaboard. The principal activity involves mining, preparation, and marketing of thermal coal, sold to power generators.